Literature DB >> 24497180

TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis.

Scott M Reba1, Qing Li, Sophia Onwuzulike, Xuedong Ding, Ahmad F Karim, Yeritza Hernandez, Scott A Fulton, Clifford V Harding, Christina L Lancioni, Nancy Nagy, Myriam E Rodriguez, Pamela A Wearsch, Roxana E Rojas.   

Abstract

We have previously demonstrated that mycobacterial lipoproteins engage TLR2 on human CD4(+) T cells and upregulate TCR-triggered IFN-γ secretion and cell proliferation in vitro. Here we examined the role of CD4(+) T-cell-expressed TLR2 in Mycobacterium tuberculosis (MTB) Ag-specific T-cell priming and in protection against MTB infection in vivo. Like their human counterparts, mouse CD4(+) T cells express TLR2 and respond to TLR2 costimulation in vitro. This Th1-like response was observed in the context of both polyclonal and Ag-specific TCR stimulation. To evaluate the role of T-cell TLR2 in priming of CD4(+) T cells in vivo, naive MTB Ag85B-specific TCR transgenic CD4(+) T cells (P25 TCR-Tg) were adoptively transferred into Tlr2(-/-) recipient C57BL/6 mice that were then immunized with Ag85B and with or without TLR2 ligand Pam3 Cys-SKKKK. TLR2 engagement during priming resulted in increased numbers of IFN-γ-secreting P25 TCR-Tg T cells 1 week after immunization. P25 TCR-Tg T cells stimulated in vitro via TCR and TLR2 conferred more protection than T cells stimulated via TCR alone when adoptively transferred before MTB infection. Our findings indicate that TLR2 engagement on CD4(+) T cells increases MTB Ag-specific responses and may contribute to protection against MTB infection.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CD4+ T cells; Mycobacterium tuberculosis; Toll-like receptor 2

Mesh:

Substances:

Year:  2014        PMID: 24497180      PMCID: PMC4112943          DOI: 10.1002/eji.201344100

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  42 in total

1.  Cutting edge: TLR2 directly triggers Th1 effector functions.

Authors:  Takayuki Imanishi; Hiromitsu Hara; Shinobu Suzuki; Nobutaka Suzuki; Shizuo Akira; Takashi Saito
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

2.  TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.

Authors:  Blandine C Mercier; Anne Cottalorda; Charles-Antoine Coupet; Jacqueline Marvel; Nathalie Bonnefoy-Bérard
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

3.  Modulation of naive CD4+ T-cell responses to an airway antigen during pulmonary mycobacterial infection.

Authors:  Mursalin M Anis; Scott A Fulton; Scott M Reba; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

Review 4.  Memory T cells need CD28 costimulation to remember.

Authors:  Alina C Boesteanu; Peter D Katsikis
Journal:  Semin Immunol       Date:  2009-03-05       Impact factor: 11.130

5.  Codominance of TLR2-dependent and TLR2-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo.

Authors:  Eleanor Z Kincaid; Andrea J Wolf; Ludovic Desvignes; Sebabrata Mahapatra; Dean C Crick; Patrick J Brennan; Martin S Pavelka; Joel D Ernst
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

6.  A Toll-like receptor-2-directed fusion protein vaccine against tuberculosis.

Authors:  Baolin Wang; Marcela Henao-Tamayo; Marisa Harton; Diane Ordway; Crystal Shanley; Randall J Basaraba; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2007-07

Review 7.  Cell-mediated immune responses in tuberculosis.

Authors:  Andrea M Cooper
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

8.  Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype.

Authors:  V Rao; N Dhar; H Shakila; R Singh; A Khera; R Jain; M Naseema; C N Paramasivan; P R Narayanan; V D Ramanathan; A K Tyagi
Journal:  Scand J Immunol       Date:  2005-05       Impact factor: 3.487

9.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

10.  Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection.

Authors:  Alena M Gallegos; Eric G Pamer; Michael S Glickman
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

View more
  18 in total

Review 1.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

2.  Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function.

Authors:  Ahmad Faisal Karim; Scott M Reba; Qing Li; W Henry Boom; Roxana E Rojas
Journal:  Eur J Immunol       Date:  2017-07-18       Impact factor: 5.532

Review 3.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

Review 4.  Extracellular vesicles and infectious diseases: new complexity to an old story.

Authors:  Jeffrey S Schorey; Clifford V Harding
Journal:  J Clin Invest       Date:  2016-04-01       Impact factor: 14.808

Review 5.  TLR2 as a Therapeutic Target in Bacterial Infection.

Authors:  Morgan E Simpson; William A Petri
Journal:  Trends Mol Med       Date:  2020-06-17       Impact factor: 11.951

6.  Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages.

Authors:  Jaffre J Athman; Ying Wang; David J McDonald; W Henry Boom; Clifford V Harding; Pamela A Wearsch
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

7.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Suppression of Th1 Priming by TLR2 Agonists during Cutaneous Immunization Is Mediated by Recruited CCR2+ Monocytes.

Authors:  Christopher T Johndrow; Michael F Goldberg; Alison J Johnson; Tony W Ng; Shajo Kunnath-Velayudhan; Gregoire Lauvau; Daniel H Kaplan; Graeme H Gossel; Ulrich D Kadolsky; Andrew J Yates; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2018-11-19       Impact factor: 5.422

9.  Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells.

Authors:  Brian D Sinnott; Byung Park; Mardi C Boer; Deborah A Lewinsohn; Christina L Lancioni
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

10.  Calcitriol attenuates TLR2/IL-33 signaling pathway to repress Th9 cell differentiation and potentially limits the pathophysiology of rheumatoid arthritis.

Authors:  Shachi Pranjal Vyas; Rajeshwar Nath Srivastava; Ritobrata Goswami
Journal:  Mol Cell Biochem       Date:  2020-09-23       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.